USD 0.0
(-3.92%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 247.1 Thousand USD | -44.75% |
2022 | 447.26 Thousand USD | 2.84% |
2021 | 434.9 Thousand USD | 6.2% |
2020 | 409.5 Thousand USD | 14.82% |
2019 | 356.64 Thousand USD | 1.64% |
2018 | 350.9 Thousand USD | -37.55% |
2017 | 561.93 Thousand USD | 0.0% |
2015 | 484.82 Thousand USD | -18.82% |
2014 | 597.23 Thousand USD | 120207.76% |
2013 | 496.42 USD | 0.0% |
2009 | 535.28 Thousand USD | 10278.49% |
2008 | -5259.00 USD | -2922.41% |
2007 | -174.00 USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 241.11 Thousand USD | -5.7% |
2024 Q1 | 255.7 Thousand USD | 3.48% |
2023 Q4 | 247.1 Thousand USD | -10.83% |
2023 Q2 | 447.26 Thousand USD | 0.0% |
2023 Q1 | 447.26 Thousand USD | 0.0% |
2023 FY | 247.1 Thousand USD | -44.75% |
2023 Q3 | 277.1 Thousand USD | -38.04% |
2022 Q1 | 434.9 Thousand USD | -0.0% |
2022 Q2 | 447.26 Thousand USD | 2.84% |
2022 Q3 | 447.26 Thousand USD | 0.0% |
2022 FY | 447.26 Thousand USD | 2.84% |
2022 Q4 | 447.26 Thousand USD | 0.0% |
2021 Q3 | 431.4 Thousand USD | 0.25% |
2021 FY | 434.9 Thousand USD | 6.2% |
2021 Q2 | 430.33 Thousand USD | -7.5% |
2021 Q1 | 465.23 Thousand USD | 0.0% |
2021 Q4 | 434.9 Thousand USD | 0.81% |
2020 FY | 409.5 Thousand USD | 14.82% |
2019 FY | 356.64 Thousand USD | 1.64% |
2018 FY | 350.9 Thousand USD | -37.55% |
2017 FY | 561.93 Thousand USD | 0.0% |
2015 FY | 484.82 Thousand USD | -18.82% |
2014 Q4 | 597.23 USD | 1.96% |
2014 Q2 | 567.51 USD | 5.51% |
2014 FY | 597.23 Thousand USD | 120207.76% |
2014 Q1 | 537.85 USD | 8.34% |
2014 Q3 | 585.77 USD | 3.22% |
2013 Q4 | 496.42 USD | -26.64% |
2013 FY | 496.42 USD | 0.0% |
2013 Q3 | 676.67 USD | 14.26% |
2013 Q1 | -34.41 USD | 0.0% |
2013 Q2 | 592.24 USD | 1820.98% |
2010 Q2 | 480.59 Thousand USD | -9.53% |
2010 Q1 | 531.22 Thousand USD | -0.76% |
2010 Q3 | 484.73 Thousand USD | 0.86% |
2009 Q2 | 530.79 Thousand USD | 36833.08% |
2009 Q1 | -1445.00 USD | 0.0% |
2009 FY | 535.28 Thousand USD | 10278.49% |
2009 Q4 | 535.28 Thousand USD | 0.47% |
2009 Q3 | 532.77 Thousand USD | 0.37% |
2008 FY | -5259.00 USD | -2922.41% |
2007 FY | -174.00 USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q2 | -7947.00 USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
China Medicine Corporation | 9.03 Million USD | 97.265% |
DH Enchantment Inc. | 409.44 Thousand USD | 39.648% |
Exlites Holdings International, Inc. | - USD | -Infinity% |
Itonis, Inc. | 909.99 Thousand USD | 72.845% |
MediPal Holdings Corporation | -1.49 Billion USD | 100.017% |
PD-Rx Pharmaceuticals, Inc. | -6.83 Million USD | 103.616% |
Pharmagen, Inc. | 4362.26 USD | -5564.678% |
Suzuken Co., Ltd. | -1.17 Billion USD | 100.021% |